TY - JOUR
T1 - The importance of adjusting for treatment crossover bias in oncology clinical trials: An analysis of the EGF104900 trial in metastatic breast cancer (mBC).
JO - Journal of Clinical Oncology
PY - 2013/05/20
AU - Paracha N
AU - Davies A
AU - Latimer N
AU - Parker C
AU - Mealing S
AU - Scott D
AU - Padhiar A
AU - Schulpher M
AU - Wang Q
ED -
DO - DOI: 10.1200/jco.2013.31.15_suppl.636
PB - American Society of Clinical Oncology (ASCO)
VL - 31
IS - 15_suppl
SP - 636
EP - 636
Y2 - 2025/07/30
ER -